Mar. 28 2024
Source Page: Uncontrolled novel benzodiazepines: 2024 updateFound: Seizures made by law enforceme nt in Sweden have been labelled as ‘sample for research’. 3.33.
Asked by: Lord Hunt of Kings Heath (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what plans they have to provide funding for biomedical research into (1) the causes of, and (2) potential cures for, myalgic encephalomyelitis.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department provides funding for research through the National Institute for Health and Care Research (NIHR). The NIHR welcomes funding applications for research into any aspect of human health, including on the causes of, and potential cures for, myalgic encephalomyelitis (ME). These applications are subject to peer review and judged in open competition, with awards being made based on the importance of the topic to patients and health and care services, value for money and scientific quality. In all disease areas, the amount of NIHR funding depends on the volume and quality of scientific activity.
In the last five years, the NIHR has allocated approximately £3.44 million to support nine research projects on ME and chronic fatigue syndrome. The NIHR is also co-funding, with the Medical Research Council, a £3.2 million study (‘DecodeME’) which is the world’s largest genetic study of the disease.
Mar. 25 2024
Source Page: Digital skills, channel preference, and access needs: Personal Independence Payment customersFound: #research- and-analysis -publications If you would like to know more about DWP research, email socialresearch
Mar. 25 2024
Source Page: Digital skills, channel preferences and access needs: DWP customersFound: Asperger’s syndrome / Autism / Autism Spectrum Disorder MUSCULO -SKELETAL / PHYSICAL INJURY 6.
Mar. 21 2024
Source Page: Flagship youth employment programme hits one million milestoneFound: Status syndrome . Bloomsbury, London. Marmot M, Wilkinson RG. 2006.
Mar. 19 2024
Source Page: FOI responses published by MOD: week commencing 18 March 2024Found: (Accessed Sep 16). 4-N-3 JSP 950 Lft 6 -7-7 (V1. 6 Aug 19) Chronic fatigue syndrome and associated
Mar. 14 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 29 May 2023Found: In the UK, data from the General Practice Research Database (GPRD) yielded an overall period prevalence
Mar. 14 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023Found: depression, anxiety depression, anxiodepressive syndrome)7 Migraine 7 Headache 2 Chronic renal failure
Mar. 14 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023Found: fatigue syndrome, Confusional state, Conjunctivitis, Constipation, Contraindication to vaccination
Mar. 14 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023Found: Datalink DAP Database access provider DRE Digital Research Environment (NL) DSRU Drug Safet y Research